Eli Lilly’s Alzheimer’s therapy, donanemab, has received FDA approval, offering new hope for patients with early symptomatic Alzheimer’s disease. The newly approved treatment, branded Kisunla, is set to challenge existing therapies from Eisai and Biogen.  Clinical trials have shown Kisunla to be effective for individuals in the mild cognitive impairment or mild dementia stages of […] Continue reading ->
Nestlé’s shareholders have a golden opportunity to call on the food giant to promote healthier lives in almost two hundred countries by backing a bold resolution at the multinational’s Annual General Meeting this week. Doing so can protect their profits in the long-haul. Backed by a coalition of five institutional investors with $ 1.68 trillion […] Continue reading ->
The ‘forgotten crisis’ of Afghanistan has exposed more and more young Afghans to mental health problems and drug abuse amid dwindling donor support and crumbling healthcare under the Taliban regime, said experts at a high-level side event at the recent meeting of the Commission on Narcotic Drugs in Vienna Austria. Since the Taliban imposed a […] Continue reading ->
COPENHAGEN –  In Lebanon, international donors are supporting a network of public primary health care centers to test for diabetes and other noncommunicable diseases (NCDs), offering treatment equally to Lebanese nationals and Syrian refugees who are unlikely to return anytime soon to their war-torn homeland.  In Kenya, a new national insurance law aims to make […] Continue reading ->
COPENHAGEN –  While conflict and natural disasters are usually played out in the media against dramatic scenes of mass casualty response and rescue teams, there’s an iceberg of chronic health conditions that can be even more life threatening and these need far greater attention in emergency response.  That is the theme of a global high […] Continue reading ->